Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
We send one confirmation email first. Only emails about IMNN, unsubscribe in one click. Privacy
| Drug | Indication | Most advanced trial | Status |
|---|---|---|---|
| 5% Dextrose Solution | Hepatocellular Carcinoma | Phase 3 · NCT00617981 | Completed |
| Lyso-Thermosensitive Liposome Doxorubici | Hepatocellular Carcinoma | Phase 3 · NCT02112656 | Completed |
| Dummy Infusion | Hepatocellular Carcinoma | Phase 3 · NCT02112656 | Completed |
| PEG-PEI-cholesterol Lipopolymer-encased | Epithelial Ovarian Cancer | Phase 3 · NCT06915025 | Recruiting |
| ThermoDox in combination with Microwave | Breast Cancer | Phase 1/2 · NCT00826085 | Completed |
| Doxorubicin | Colon Cancer Liver Metastasis | Phase 2 · NCT01464593 | Terminated |
| IMNN-101 | SARS CoV 2 Infection | Phase 1/2 · NCT06283459 | Completed |
| Pegylated Liposomal Doxorubicin Hydrochl | Prostate Cancer | Phase 1 · NCT00061867 | Completed |
Also used in these trials (approved or third-party drugs, not IMNN's own candidates): Carboplatin, Paclitaxel, Olaparib, Niraparib, Bevacizumab, Doxorubicin Hydrochloride, Cyclophosphamide.
Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it
IMNN holds $6.9M in cash and short-term investments (as of Jun 30, 2026) and burns about $3.5M/quarter from operations, an estimated runway of 5.9 months at that rate (BioRadar estimate, not company guidance).
Dilution pressure: 65 · High
Such conditions raise substantial doubts about the Company’s ability to continue as a going concern.10-Q, Aug 2026
Recent financing filings on SEC EDGAR:
Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when IMNN files for a raise →
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for IMNN and every other ticker you follow. Card required, cancel anytime.
Start 7-day free trial →